Literature DB >> 1693082

Lymphokine control of in vivo immunoglobulin isotype selection.

F D Finkelman1, J Holmes, I M Katona, J F Urban, M P Beckmann, L S Park, K A Schooley, R L Coffman, T R Mosmann, W E Paul.   

Abstract

Several specific conclusions can be drawn from these studies: 1. IL-4 is required for the generation of both primary polyclonal and secondary antigen-specific IgE responses in vivo. 2. IL-4 is required to maintain established, ongoing, antigen-specific and polyclonal IgE responses. 3. Most, but not all, polyclonal IgE production during a secondary immune response is IL-4-dependent. Memory B cells that have already switched to IgE at the DNA level may no longer require stimulation with IL-4 to be induced to secrete IgE. 4. The generation of a secondary IgE response is not dependent upon the presence of IL-4 during primary immunization. However, if IL-4 is not present during primary immunization, it is required during secondary immunization for the generation of an IgE response. 5. IL-4 does not appear to be required for the generation of in vivo IgG1 responses, and in at least some instances, does not contribute significantly to the generation of IgG1 responses in vivo. 6. A late-acting form of T-cell help other than IL-4 appears to be required for the generation of an IgE, but not an IgG1 response. 7. An antibody that inhibits IL-4 binding to IL-4 receptors affects Ig isotype selection in the same way as an antibody that neutralizes IL-4. 8. IFN-gamma can act in both spontaneous and induced immune responses to suppress IgE production. 9. IFN-gamma can also suppress IgG1 production and stimulate IgG2a production. However, IFN-gamma appears to suppress polyclonal IgG1 responses more than antigen-specific IgG1 responses, and it enhances, but is not required for, the generation of IgG2a responses. 10. IFN-alpha appears to resemble IFN-gamma in its ability to inhibit IgE and enhance IgG2a responses in GaM delta-injected mice, but it requires the presence of IFN-gamma to suppress IgG1 production in these mice. 11. Both IFN-alpha and IFN-gamma appear to be able to decrease IgE production in some human patients. 12. There is no direct evidence that IL-5 contributes to the generation of in vivo antibody responses. Two general conclusions may also be drawn.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693082     DOI: 10.1146/annurev.iy.08.040190.001511

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  365 in total

1.  Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.

Authors:  L Pan; S Sato; J P Frederick; X H Sun; Y Zhuang
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 2.  Interleukin 12 and innate molecules for enhanced mucosal immunity.

Authors:  P N Boyaka; J W Lillard; J McGhee
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 3.  Molecular mechanisms in T helper phenotype development.

Authors:  J D Farrar; S H Ranganath; K M Murphy
Journal:  Springer Semin Immunopathol       Date:  1999

Review 4.  Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis.

Authors:  M W Cunningham
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats.

Authors:  B G Xiao; Y M Huang; J S Yang; L Y Xu; H Link
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

6.  Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection.

Authors:  A George-Chandy; N Mielcarek; I Nordström; J Holmgren; K Eriksson
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Xenobiotic metal-induced autoimmunity: mercury and silver differentially induce antinucleolar autoantibody production in susceptible H-2s, H-2q and H-2f mice.

Authors:  M Hansson; M Abedi-Valugerdi
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

8.  Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta.

Authors:  Vitaly Vasilevko; Viorela Pop; Hyun Jin Kim; Tommy Saing; Charles C Glabe; Saskia Milton; Edward G Barrett; Carl W Cotman; David H Cribbs; Elizabeth Head
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

9.  Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.

Authors:  R D Bungiro; M Goldberg; P K Suri; P M Knopf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

10.  The 60-kDa heat shock protein modulates allograft rejection.

Authors:  O S Birk; S L Gur; D Elias; R Margalit; F Mor; P Carmi; J Bockova; D M Altmann; I R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.